Integra LifeSciences to Present At Two Conferences in February
PLAINSBORO, N.J., Jan 29, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at two conferences in February.
On Thursday, February 12, 2009 at 8:00 AM, Gerry Carlozzi, Executive Vice President and Chief Operating Officer of Integra, will be presenting at the Deutsche Bank Small and Mid Cap Growth Conference at The Ritz-Carlton in Naples, Florida. A webcast will not be available for this conference.
On Tuesday, February 24, 2009 at 2:20 PM, Gerry Carlozzi will again be presenting at the Canaccord Adams Musculoskeletal Conference at the University of Nevada, Las Vegas Student Union. An audio webcast for this conference will be available via a link at our website at www.Integra-LS.com in the Investor's Relations section.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of clinically relevant, innovative and cost-effective surgical implants and medical instruments. The company's products are used to treat millions of patients every year, primarily in neurosurgery, orthopedics and general surgery. Integra's headquarters are in Plainsboro, New Jersey, and it has research and manufacturing facilities throughout the world. www.Integra-LS.com.
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2007 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
IART-G
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Integra LifeSciences Holdings Corp.
Integra LifeSciences Holdings Corporation
John B. Henneman, III, Executive Vice
President, Finance and Administration, and
Chief Financial Officer
(609) 936-2481
jhenneman@Integra-LS.com
Karen Mroz-Bremner, Senior Manager,
Corporate Development and Investor Relations
(609) 936-6929
Karen.mroz-bremner@Integra-LS.com
(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.
News Provided by COMTEX